PMC4007744_01
ASD secundum (A) and Cor triatriatum sinister with fenestration (f).
CRIM.CARDIOLOGY2011-740981.002.jpg
PMC4007744_01_CRIM.CARDIOLOGY2011-740981.002.jpg
fig2
Occlutech Figulla device was deployed.
CRIM.CARDIOLOGY2011-740981.003.jpg
PMC4007744_01_CRIM.CARDIOLOGY2011-740981.003.jpg
fig3
Device was deployed. (Figure 3) TEE revealed proper site of device without obstruction, no residual shunt, and residual fenestration of cor triatriatum membrane was 12 mm.
TEE after procedure demonstrate no obstruction blood flow through fenestration of cor triatriatum membrane (f).
CRIM.CARDIOLOGY2011-740981.004.jpg
PMC4007744_01_CRIM.CARDIOLOGY2011-740981.004.jpg
fig4
We used TEE to recheck that the device will not occlude pulmonary venous return, and TEE revealed no turbulence flow of pulmonary veins and no turbulence flow of blood flow through fenestration of cor triatriatum membrane (Figure 4).
After releasing the device.
CRIM.CARDIOLOGY2011-740981.005.jpg
PMC4007744_01_CRIM.CARDIOLOGY2011-740981.005.jpg
fig5
The device was released (Figure 5).